MICROLEARNING PROGRAM

From the Podium to Practice: Translating Emerging ATTR-CM Evidence Across Underserved and Underrecognized Populations

0.25 AMA PRA Credits PER MODULE

Maximum Credit Amount: 1.00

Credit Type: ACCME
Release: 5/29/2026
Expiration: 5/29/2027

Supporter Acknowledgement

This educational activity is supported by an independent educational grant from BridgeBio Pharma, Inc.
Overview
Learning Objectives
CME/ Information
Faculty and Disclosures
Instructions

Program Overview

From the Podium to Practice: Translating Emerging ATTR-CM Evidence Across Underserved and Underrecognized Populations is a four-part, mobile-accessible CME series designed to help clinicians translate emerging congress data into evidence-based care for patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Released approximately 45–60 days following four major cardiovascular congresses, each module focuses on critical gaps in recognition, diagnosis, and treatment across underrecognized patient populations, including women, African American patients with the p.Val142Ile variant, and patients presenting with atrial fibrillation or conduction system disease.

Through expert faculty commentary, interactive case-based learning, infographic-driven evidence summaries, embedded polling, and AI-generated patient video cases, learners will apply emerging clinical evidence to real-world diagnostic and treatment decisions. All four modules are housed within this learning experience and are designed for busy healthcare professionals seeking practical, immediately applicable education in ATTR-CM care.

Target Audience

This educational initiative is designed for cardiologists, including general cardiologists, heart failure specialists, and electrophysiologists, as well as internal medicine physicians, primary care clinicians, physician assistants, nurse practitioners, nurses, pharmacists, and other healthcare professionals involved in the recognition and management of transthyretin amyloid cardiomyopathy.

Supporter Acknowledgement

This educational activity is supported by an independent educational grant from BridgeBio Pharma, Inc.

Learning Objectives

Upon completion of this activity, the participant should be able to:
  • Identify female-specific ATTR-CM phenotypic features.
  • Apply adjusted diagnostic criteria in women presenting with HFpEF and ventricular wall thickening.
  • Select ATTR-CM therapy in women using emerging sex-stratified evidence, individualized to disease stage and functional status.
  • Apply structured diagnostic and genetic screening protocols to African American patients with HFpEF, wall thickening, or unexplained LVH, distinguishing V142I ATTR-CM from hypertensive cardiomyopathy.
  • Optimize treatment among available ATTR-CM therapies for p.Val142Ile patients based on disease stage, comorbidities, and cross-class comparative evidence; initiate cascade genetic screening.
  • Implement a structured ATTR-CM screening protocol for patients presenting to electrophysiologists with AF, AV block, bundle branch block, or unexplained conduction system disease.
  • Apply emerging arrhythmia-specific trial evidence to modify procedural planning, anticoagulation decisions, and TTR-directed therapy sequencing in patients with confirmed ATTR-CM and concomitant AF or conduction system disease.
  • Synthesize 2026 congress evidence across TTR stabilizer and silencer classes to identify practice-changing findings, recognize remaining guideline gaps

Accredited Provider

This activity is jointly provided by Global Education Group and Iridium Continuing Education.

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Iridium. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty, Staff, and Planners’ Disclosures

Name of Planner or Manager Reported Financial Relationship
Conor Hughes Nothing to disclose
Andrea Funk Nothing to disclose
Ashley Cann Nothing to disclose
Lauren Sinclair Nothing to disclose
Deborah Sharkey Nothing to disclose
Matthew Stern Nothing to disclose
Alyssa Rossi Nothing to disclose
Monique Walters Nothing to disclose
Melissa Wiles Nothing to disclose
Amit Goyal, MD, MAS (Chair) Consulting Fee (e.g. Advisory Board) Shockwave Medical     

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Iridium do not recommend the use of any agent outside of the labeled indications.The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosures of Relevant Financial Relationship(s)

​Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:
Amit Goyal, MD MAS
(chair)
Co-Founder, The CardioNerds
Editor-in-Chief, US Cardiology Review
Assistant Professor of Medicine, UTSW
Structural Interventional Cardiologist, Dallas VA
Consulting Fee (e.g. Advisory Board): Shockwave Medical      
Pooja Prasad, MD
Assistant Clinical Professor
Advanced Heart Failure & Transplant Cardiology | Pulmonary Hypertension
University of California, San Francisco
San Francisco, CA
Nothing to disclose

Instructions to Receive Credit

In order to receive credit for this activity, the participant must: 

  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • Participate in the on-demand activity
  • Complete the posttest with a score of 70% or higher
  • Complete the evaluation

A statement of credit will be issued within four weeks of receipt of a completed activity evaluation form.

Fee Information and Refund/Cancellation Policy

There is no fee for this educational activity.

Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com

System Requirements

System requirements

Learning program modules